CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in CollPlant Biotechnologies Ltd as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- 0 vs. Q4 2022
- Shares held
- 1.55M
- −28.3K (−1.8%) vs. Q4 2022
- Total value
- $10.9M
- −$2.20M (−16.9%) vs. Q4 2022
- New holders
- 2
- 5 more added
- Sold out
- 2
- 4 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 100 | $702 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 171 | $1.20K | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 242 | $1.70K | 0.00% | +242 | New |
| National Bank of Canada | 250 | $1.70K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 500 | $3.51K | 0.00% | +100+25.0% | Added |
| Geneos Wealth Management Inc. | 750 | $5.26K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 3,600 | $25.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 7,389 | $51.9K | 0.00% | +2,589+53.9% | Added |
| UBS Group AG | 8,004 | $56.2K | 0.00% | +964+13.7% | Added |
| Parallel Advisors, LLC | 9,614 | $67.5K | 0.00% | −3,025−23.9% | Reduced |
| Shay Capital LLC | 10,000 | $70.2K | 0.03% | +10,000 | New |
| Simon Quick Advisors, LLC | 13,202 | $92.7K | 0.01% | −2,474−15.8% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,120 | $162.3K | 0.00% | −70−0.3% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 65,911 | $463.0K | 0.02% | +4,861+8.0% | Added |
| Brown Advisory Inc | 73,849 | $518.4K | 0.00% | 00.0% | Unchanged |
| Villere St Denis J & Co LLC | 289,797 | $2.03M | 0.15% | +2,650+0.9% | Added |
| Investment Management of Virginia LLC | 463,899 | $3.26M | 0.62% | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 577,909 | $4.06M | 9.19% | −27,528−4.5% | Reduced |
| Credit Suisse AG | 0 | $0 | 0.00% | −6,100−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,490−100.0% | Sold out |